Neurocrine’s Ingrezza, approved…
Neurocrine’s Ingrezza, approved to treat certain uncontrolled movements, failed to [...]
Drug pricing, layoffs, personnel…
Drug pricing, layoffs, personnel moves and other topics drove reader [...]
Pharma giant AstraZeneca extended…
Pharma giant AstraZeneca extended its supply deal with Michigan-based medical [...]
CMS’ Innovation Center has…
CMS’ Innovation Center has released two new drug pricing models [...]
Boehringer’s Jascayd can now crack…
Boehringer’s Jascayd can now crack open the rare progressive pulmonary [...]
Slated for a Dec. 26 decision on…
Slated for a Dec. 26 decision on Cytokinetics’ aficamten, the [...]
Samsung Bio’s U.S. subsidiary…
Samsung Bio’s U.S. subsidiary will pay $280 million to acquire [...]
¿Por cuánto tiempo puedes tomar antidepresivos?
Estos medicamentos, creados para hacerte sentir bien, son difíciles de [...]
Trump Announces Pricing Deals With Nine Drugmakers
The companies were the latest to agree to sell drugs [...]
F.D.A. Turmoil Keeps Spotlight on Its Commissioner
The agency’s high-level turnover and conflicting policy decisions on drug [...]